| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | -0.0042 | 0.9 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |